The FDA study, which included 1,500 participants, showed that consumers were significantly more likely to recall risks and benefits. Read more
A U.S. District Court in Pennsylvania has ruled that updated product warnings concerning the diabetes drug Avandia may not have adequately warned users of the risks of heart attack and strok... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.